The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NCCTG N0872 (Alliance): A randomized placebo-controlled phase II trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma (GBM).
 
Evanthia Galanis
No Relationships to Disclose
 
S. Keith Anderson
Patents, Royalties, Other Intellectual Property - 20090298082
 
Panagiotis Anastasiadis
No Relationships to Disclose
 
David Dinh Tran
No Relationships to Disclose
 
Suriya A. Jeyapalan
Speakers' Bureau - Sigma-Tau
 
Daniel M. Anderson
No Relationships to Disclose
 
Timothy J. Kaufmann
No Relationships to Disclose
 
Caterina Giannini
No Relationships to Disclose
 
Jan C. Buckner
Consulting or Advisory Role - Merck Serono
Travel, Accommodations, Expenses - Genentech/Roche
 
David Schiff
Consulting or Advisory Role - Genentech; HERON; Meditech; Sigma-Tau